Functionally, recombinant human SLPI (rhSLPI) promoted the clonogenic survival of KKU-100 cells in a dose-dependent manner, providing direct evidence that SLPI enhances CCA cell proliferation and survival [22]. Here, SLPI is linked to cholangiocarcinoma.